Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCV13 immunogenicity in children with type 1 diabetes mellitus
2013-001024-19Phase 4Completed
- Sponsor
- University of Oxford
- Start
- May 2013
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of pneumococcal 13-valent conjugate vaccine in pneumococcal disease, sponsored by University of Oxford. Started May 2013; status: completed.
02
Drugs
pneumococcal 13-valent conjugate vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on 2013-001024-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001024-19.